In insulin-naive T2D, fixed-dose weekly efsitora was noninferior to daily glargine for reducing HbA(1c) at 52 wk. Tanner M. Ann Intern Med 2025;178:JC113.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tanner M. In insulin-naive T2D, fixed-dose weekly efsitora was noninferior to daily glargine for reducing HbA(1c) at 52 wk. Ann Intern Med 2025;178:JC113.
PMID: 41052450